Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
Crops and drugs created using powerful gene-editing techniques such as CRISPR–Cas9 might not need to be regulated by the strict European Union rules that govern genetically modified organisms (GMOs), according to a formal opinion from an advocate general in the European Court of Justice.